TXN and cardiac hypertrophy: On the other hand, in Trx-overexpressing mice, the progression of various types of heart failure (Dox-induced cardiomyopathy [22], ischemic heart disease [23] and angiotensin II-induced cardiac hypertrophy [24]) was suppressed.